NORM-HF Pivotal Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 800 participants.

Also called NCT07574593

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Not applicable
Enrolled
  • 800 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07574593
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07574593. Randomized; no masking; primary purpose prevention. Start 2026-05-29 (actual); primary completion 2029-08 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
NORM-HF Pivotal Study
Acronym
NORM-HF
Condition
Heart Failure
Condition
NYHA Class III Heart Failure
Condition
NYHA Class II Heart Failure
Intervention (Device)
IVC Sensor
Lead sponsor
Foundry Innovation & Research 1, Limited (FIRE1) (class: industry)
Collaborator
NAMSA (class: other)
Collaborator
Baim Institute for Clinical Research (class: other)

Record details

Record id
cardio:ct-nct07574593
Content hash
3d964eac6a714e38dbcc00f65d9ecb7db164075a8213deccf8c0987c00425554